HealthDay - WEDNESDAY, Nov. 25 (HealthDay News) — Adding the drug cetuximab
to neoadjuvant chemotherapy can shrink tumors and boost the odds of
successful surgery in colorectal cancer patients with inoperable
metastatic liver lesions, new research suggests.

Źródło: http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/hsn/20091126/hl_hsn/cetuximabhelpstreatcolorectalcancer

Comments are closed